Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss
A Randomised, Evaluator-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy of a Novel Microneedle and Laser-Based Medical Device For The Treatment of Androgenetic Alopecia in Adult Males
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- StimuSIL
- Participants (registry)
- 82
- Start
- June 2023
- Primary completion
- August 2024
- Study completion
- October 2024
- Last registry update
- May 2025
- Countries
- Turkey
Conditions studied: Male Pattern Baldness, Androgenetic Alopecia, Hair Loss/Baldness, Hair Loss, Pattern Baldness
Interventions: SAGA-001 (A), SAGA-001 (B)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.